Kristen Harrington was Appointed as Chief Commercial Officer at ADC Therapeutics

Date of management change: January 11, 2022 

What Happened?

, -based ADC Therapeutics Appointed Kristen Harrington as Chief Commercial Officer

 

About the Company

ADC Therapeutics is a commercial-stage biotechnology company improving the lives of those affected by cancer with our next-generation, targeted antibody drug conjugates (ADCs). With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, we are working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London (R&D), New Jersey (Clinical and Commercial), and the San Francisco Bay Area (CMC). Our highly skilled global team is committed to confronting cancer with the full potential of our science, bringing unique, targeted therapies and hope to patients and their families.

 

About the Person

Kristen Harrington is Chief Commercial Officer at ADC Therapeutics. Previously, Kristen held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Michaels Shawn, Davis Greg, pham tam, Reasoner Brett, Herrgesell Kelly, O'Neill Maureen, Lynch Christine, Bowe Tim, Materson Kevin, Pride Vronn, Gadi Santosh

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.